Clarivate (NYSE:CLVT) Stock Price Down 5.2% – Here’s Why

Clarivate PLC (NYSE:CLVT)’s share price dropped 5.2% during trading on Monday . The stock traded as low as $2.27 and last traded at $2.2660. Approximately 176,625 shares were traded during mid-day trading, a decline of 97% from the average session volume of 6,808,156 shares. The stock had previously closed at $2.39.

Analyst Upgrades and Downgrades

CLVT has been the topic of a number of research reports. Barclays increased their price objective on shares of Clarivate from $2.40 to $2.50 and gave the company an “underweight” rating in a research note on Tuesday, July 7th. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a report on Wednesday, June 24th. Four investment analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $2.98.

Clarivate Price Performance

The firm has a market capitalization of $1.49 billion, a PE ratio of -11.12 and a beta of 1.38. The company has a 50-day moving average price of $2.34 and a 200-day moving average price of $2.50. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84.

Clarivate (NYSE:CLVT) last announced its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.04. The firm had revenue of $585.50 million during the quarter, compared to the consensus estimate of $569.50 million. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The firm’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Sell-side analysts forecast that Clarivate PLC will post 0.65 EPS for the current year.

Institutional Trading of Clarivate

Several hedge funds and other institutional investors have recently bought and sold shares of CLVT. Personal CFO Solutions LLC acquired a new position in Clarivate in the 1st quarter valued at $30,000. FreeGulliver LLC acquired a new stake in shares of Clarivate during the first quarter worth $30,000. Principal Financial Group Inc. acquired a new stake in shares of Clarivate during the first quarter worth $32,000. M&T Bank Corp purchased a new stake in shares of Clarivate in the fourth quarter valued at $34,000. Finally, Parallel Advisors LLC grew its position in shares of Clarivate by 94.2% in the first quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock valued at $35,000 after purchasing an additional 6,687 shares during the period. 85.72% of the stock is owned by hedge funds and other institutional investors.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.